Logo image of SLNH

SOLUNA HOLDINGS INC (SLNH) Stock Fundamental Analysis

NASDAQ:SLNH - Nasdaq - US5835433013 - Common Stock - Currency: USD

0.55  -0.01 (-1.61%)

After market: 0.57 +0.02 (+3.64%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to SLNH. SLNH was compared to 284 industry peers in the Software industry. SLNH may be in some trouble as it scores bad on both profitability and health. SLNH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year SLNH has reported negative net income.
SLNH had a negative operating cash flow in the past year.
In the past 5 years SLNH reported 4 times negative net income.
In multiple years SLNH reported negative operating cash flow during the last 5 years.
SLNH Yearly Net Income VS EBIT VS OCF VS FCFSLNH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

Looking at the Return On Assets, with a value of -72.89%, SLNH is doing worse than 86.97% of the companies in the same industry.
Industry RankSector Rank
ROA -72.89%
ROE N/A
ROIC N/A
ROA(3y)-73.36%
ROA(5y)-40.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SLNH Yearly ROA, ROE, ROICSLNH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SLNH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SLNH Yearly Profit, Operating, Gross MarginsSLNH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200

0

2. Health

2.1 Basic Checks

SLNH does not have a ROIC to compare to the WACC, probably because it is not profitable.
SLNH has more shares outstanding than it did 1 year ago.
SLNH has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SLNH has a worse debt to assets ratio.
SLNH Yearly Shares OutstandingSLNH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
SLNH Yearly Total Debt VS Total AssetsSLNH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -5.99, we must say that SLNH is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -5.99, SLNH is not doing good in the industry: 83.80% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.99
ROIC/WACCN/A
WACC7.69%
SLNH Yearly LT Debt VS Equity VS FCFSLNH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

SLNH has a Current Ratio of 0.33. This is a bad value and indicates that SLNH is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.33, SLNH is doing worse than 93.66% of the companies in the same industry.
SLNH has a Quick Ratio of 0.33. This is a bad value and indicates that SLNH is not financially healthy enough and could expect problems in meeting its short term obligations.
SLNH has a Quick ratio of 0.33. This is amonst the worse of the industry: SLNH underperforms 93.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.33
SLNH Yearly Current Assets VS Current LiabilitesSLNH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

3

3. Growth

3.1 Past

SLNH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.49%, which is quite impressive.
The Revenue has been growing slightly by 2.85% in the past year.
The Revenue has been growing by 42.07% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)48.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.19%
Revenue 1Y (TTM)2.85%
Revenue growth 3Y38.37%
Revenue growth 5Y42.07%
Sales Q2Q%-52.7%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SLNH Yearly Revenue VS EstimatesSLNH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SLNH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLNH Price Earnings VS Forward Price EarningsSLNH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SLNH Per share dataSLNH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SLNH!.
Industry RankSector Rank
Dividend Yield N/A

SOLUNA HOLDINGS INC

NASDAQ:SLNH (6/23/2025, 6:55:52 PM)

After market: 0.57 +0.02 (+3.64%)

0.55

-0.01 (-1.61%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-16 2025-05-16
Earnings (Next)08-13 2025-08-13
Inst Owners12.37%
Inst Owner Change61.81%
Ins Owners32.37%
Ins Owner Change40.94%
Market Cap10.29M
Analysts0
Price TargetN/A
Short Float %6.23%
Short Ratio1.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.33
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-8.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.16
FCFYN/A
OCF(TTM)-0.49
OCFYN/A
SpS1.68
BVpS-0.86
TBVpS-1.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -72.89%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-73.36%
ROA(5y)-40.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 80.5%
Cap/Sales 39.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.33
Altman-Z -5.99
F-Score2
WACC7.69%
ROIC/WACCN/A
Cap/Depr(3y)126.88%
Cap/Depr(5y)534.63%
Cap/Sales(3y)102.76%
Cap/Sales(5y)154.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.85%
Revenue growth 3Y38.37%
Revenue growth 5Y42.07%
Sales Q2Q%-52.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-114.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.03%
OCF growth 3YN/A
OCF growth 5YN/A